OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
OPKO HEALTH, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Aug 28, 2026
$1.61+0.08 (+5.23%)
Close on Oct 19, 2026
- Market cap
- $1.22B
- P/E (TTM)
- –
- Dividend yield
- –
Opko Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Opko Health | Industry median |
|---|---|---|
| Market Cap | $1.20B | $166.30M |
| Enterprise Value | $903.52M | $87.12M |
| PS Ratio | 2.04 | 3.60 |
| PB Ratio | 1.01 | 2.03 |
| P/TBV Ratio | 5.34 | 2.31 |
Enterprise value
| Measure | Opko Health | Industry median |
|---|---|---|
| EV / Sales | 1.54 | 2.43 |
| EV / EBITDA | 21.79 | 14.69 |
Income (trailing twelve months)
| Measure | Opko Health | Industry median |
|---|---|---|
| Revenue | $587.90M | $57.94M |
| Gross Profit | $239.69M | $90.47M |
| Operating Income | -$48.25M | -$21.49M |
| Pretax Income | -$79.83M | -$14.72M |
| Net Income | -$72.89M | -$22.46M |
| EBITDA | $41.47M | -$17.14M |
| EPS (Diluted) | -$0.09 | -$0.83 |
Margins
| Measure | Opko Health | Industry median |
|---|---|---|
| Gross Margin | 40.8% | 52.3% |
| Operating Margin | -8.21% | -44.5% |
| Pretax Margin | -13.6% | -13.0% |
| Profit Margin | -12.4% | -39.2% |
| EBITDA Margin | 7.05% | -31.3% |
| FCF Margin | -22.8% | -8.85% |
Returns
| Measure | Opko Health | Industry median |
|---|---|---|
| Return on Equity (ROE) | -5.88% | -53.2% |
| Return on Assets (ROA) | -3.83% | -41.0% |
| Return on Invested Capital (ROIC) | -3.97% | -32.2% |
| Return on Capital Employed (ROCE) | -2.87% | -38.0% |
Growth
| Measure | Opko Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -11.5% | 6.01% |
| Revenue Growth (3Y CAGR) | -15.5% | 2.25% |
| Revenue Growth (5Y CAGR) | -15.8% | 6.42% |
Balance sheet
| Measure | Opko Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $300.76M | $62.64M |
| Total Debt | $2.69M | $120.13M |
| Net Cash (Debt) | $298.07M | $15.77M |
| Net Cash Per Share | $0.40 | $0.66 |
| Equity (Book Value) | $1.18B | $48.61M |
| Book Value Per Share | $1.59 | $1.36 |
| Tangible Book Value | $225.09M | $23.01M |
| Working Capital | $350.87M | $75.09M |
Financial position
| Measure | Opko Health | Industry median |
|---|---|---|
| Current Ratio | 3.35 | 3.30 |
| Quick Ratio | 2.56 | 2.39 |
| Debt / Equity | 0.00 | 0.51 |
| Debt / EBITDA | 0.06 | 3.35 |
| Net Debt / EBITDA | -7.19 | 2.22 |
Cash flow (trailing twelve months)
| Measure | Opko Health | Industry median |
|---|---|---|
| Operating Cash Flow | -$123.38M | -$12.39M |
| Capital Expenditures | -$10.64M | -$1.07M |
| Free Cash Flow | -$134.02M | -$20.34M |
| FCF Per Share | -$0.18 | -$0.42 |
Efficiency
| Measure | Opko Health | Industry median |
|---|---|---|
| Asset Turnover | 0.31 | 0.38 |
| Inventory Turnover | 5.43 | 2.67 |
| Revenue Per Employee | $258.42K | $398.96K |
| Profits Per Employee | -$32.04K | -$705.27K |
| Employee Count | 2,275 | 74 |
Dividends and yields
| Measure | Opko Health | Industry median |
|---|---|---|
| Earnings Yield | -6.07% | -22.8% |
| FCF Yield | -11.2% | -9.02% |
| Buyback Yield | 3.88% | -0.73% |
| Shareholder Yield | 3.88% | 0.00% |
Shares
| Measure | Opko Health | Industry median |
|---|---|---|
| Shares Outstanding | 746,328,000 | 58,139,000 |
| Shares Change (YoY) | -2.39% | 11.1% |
| Float | 421,277,000 | 49,154,900 |
| Shares Held by Insiders | 43.6% | 11.6% |
| Shares Held by Institutions | 27.2% | 59.4% |
Taxes
| Measure | Opko Health | Industry median |
|---|---|---|
| Income Tax | -$6.96M | $89.00K |
Scores
| Measure | Opko Health | Industry median |
|---|---|---|
| Altman Z-Score | -0.22 | -0.27 |
| Piotroski F-Score | 4 | 4 |
| Beneish M-Score | -2.80 | -2.62 |
Calculated by StockData from Opko Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.